Skip to main content

Regions

HIMSS23
By HIMSS TV | 01:00 pm | May 16, 2023
Lawrence Voyten, HIMSS board member and national advocacy chair, details how HIMSS chapter leaders can proactively support health equity and interoperability with their local governments.
By Jessica Hagen | 11:47 am | May 16, 2023
Webex by Cisco will integrate Voiceitt's technology into its platform for people with non-standard speech to be easily understood during virtual calls.
HIMSS23
By HIMSS TV | 07:00 am | May 16, 2023
Grady Burrows, executive director of HIT in the CLE, talks about creating a demand-driven model for diverse, local IT teams and his work with colleges and employers to build a career pipeline for youth.
By Jessica Hagen | 02:41 pm | May 15, 2023
Video game-based therapeutic company Akili and baby tech company Owlet also post first quarter results.
HIMSS23
By HIMSS TV | 01:00 pm | May 15, 2023
Lawrence Whittle, CCO at Verana Health, describes how patient data can be used to improve healthcare, including making clinical trials more efficient and helping clinicians discover which treatments yield the most value.
By Jessica Hagen | 12:28 pm | May 15, 2023
The California-based company will use the investment to scale product innovation and advance integrations with enterprise partners.
HIMSS23
By HIMSS TV | 07:00 am | May 15, 2023
Dr. John Showalter, CPO at Linus Health, describes drug therapy advances for Alzheimer's and how technology can help screen and identify at-risk patients sooner to optimize outcomes and quality of life.
By Jessica Hagen | 01:04 pm | May 12, 2023
The company saw its stock price drop upon release of its first-quarter earnings.
HIMSS23
By HIMSS TV | 01:00 pm | May 12, 2023
Dr. Jay Bhatt, managing director at Deloitte, shares recommendations on how businesses can realize productivity and retention benefits by boosting health equity for their employees.
By Jessica Hagen | 10:59 am | May 12, 2023
Andy Molnar, CEO of the Digital Therapeutics Alliance, discusses the market for digital therapeutics after Pear Therapeutics declared bankruptcy.